EL7.AI
Strategy BuilderCOT DataAdvanced NewsResearchNewEarnings CalendarEconomic Calendar
We use cookiesPrivacy Policy
EL7.AIEL7.AI

AI Financial Intelligence
Professional analysis of central bank decisions

© 2026 EL7.AI. All rights reserved.

Markets

  • News
  • Forex
  • Stocks
  • Crypto
  • Gold
  • Commodities
  • Indices
  • ETFs

Analysis

  • Fed
  • ECB
  • BLS
  • COT
  • Economic Calendar

Learn

  • Service Guide
  • Oil

Company

  • About
  • Contact
  • Data Methodology
  • AI Disclosure
  • Pricing
  • Enterprise
  • Terms
  • Privacy
  • Security
  • WhatsApp
Status data is currently unavailable

The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.

Home
Stocks
Universal Corporation
UVV

UVV Universal Corporation

Universal Corporation · NYSE
Market Closed
45.18
▼ ⁦-0.33%⁩ (-0.15)
Market Cap$1.1B
Beta0.58
52w Low52w High
43.3659.38
Last Week
⁦-1.76%⁩
Last Month
⁦-11.13%⁩
Last 3 Months
⁦-12.90%⁩
Last Year
⁦-18.34%⁩
EL7 Factor Analysis
How we score this
Overall31
Weak — below market medianValue TrapF 6/9Better than 31% of Market stocks, per EL7's modelUnsustainable dividend (payout > 100%)
FactorScoreDistributionValueAvgRank
▸
Valuation
76
60.2x▼17.8xTop tier
▸
Growth
39
-3.5%▼7.1%Bottom tier
▸
Quality
48
4.2%▼4.5%Around median
▸
Safety
45
5.5x▼2.6xAround median
▸
Capital Return
38
7.26%▲2.12%Bottom tier
▸
Momentum
27
-6.8%▼2.9%Bottom tier
▸
Sentiment
21
1▼3Bottom tier
Fair Value
Low confidenceCurrent price$45
Analyst target
No data
vs
DCF (estimate)
$111
⁦+145%⁩
Sees it clearly undervalued
⁦7.9⁩% discount · ⁦3⁩% growth

Estimates — analyst targets and a simplified DCF, not investment advice.

Compare in the screener
Premium content

Get Your Premium Account Now

  • Stock Deep Analysis
  • The Advanced News Platform
Recommended
Annual plan
$17/mo
Monthly plan
$29/mo

Analyst Consensus

This section combines price targets, revision history, analyst coverage changes, and an AI summary of what changed on the Street.

Price Target
—
Current Price $45.18
Analyst coverage
1
Recent analyst moves
  • ⬆ Upgrade2013-09-12
    Davenport
    NeutralBuy
  • ⬇ Downgrade2013-03-18
    Davenport
    BuyNeutral
Premium content
Key Financials

Ten ratios that matter, each compared against its sector median and average — so you can see whether a number is rich or cheap relative to peers in the same sector.

StockSector medianSector averagetypical sector range
MetricValuePosition within sectorVerdict
  • P/E (TTM)
    60.24x
    4.61x36.85x
    Very expensive
  • Forward P/E
    10.11x
    3.86x30.86x
    Cheap
  • EV / EBITDA
    11.71x
    2.86x22.90x
    Cheap
  • FCF Yield
    17.3%
    -37.4%14.9%
    Exceptional
  • Revenue Growth YoY
    -3.5%
    -16.7%29.2%
    Below average
  • EPS Growth YoY
    -81.8%
    -135.4%136.3%
    Below average
  • Gross Margin
    15.7%
    9.2%67.5%
    Below average
  • ROIC
    4.2%
    -29.3%20.8%
    Above average
  • Net Debt / EBITDA
    5.53x
    0.61x4.86x
    High debt
  • Dividend Yield
    7.3%
    0.9%8.3%
    High
  • Payout Ratio
    437.3%
    15.9%176.6%
    High
  • Altman Z-Score
    —
    —
Financial Analysis
|

Stock Analysis

AI-generated
Based on 2026-05-29 data

Company Overview

Universal Corporation operates primarily in purchasing, processing, and selling leaf tobacco through a broad geographic network and long-standing customer relationships, and describes itself as a leader in this market with more than 100 years of experience. Alongside its core business, it established the Universal Ingredients platform through three acquisitions, comprising the Shank's, FruitSmart, and Silva businesses, and focusing on plant-based, organic, and clean-label products and innovative solutions. In Q4 fiscal 2026, tobacco represented approximately 88% of the segment revenue reported on the earnings call, with revenue of $632 million, compared with $83 million, or approximately 12%, for the food ingredients segment.

According to EDGAR data, Q4 fiscal 2026 revenue was approximately $689.9 million, and gross profit was $73.1 million, equivalent to a gross margin of approximately 10.6%, while the company recorded a net loss of $43.3 million. The earnings call reported consolidated revenue of $715 million, up 2% year over year, but the operating result turned into a loss of $15 million compared with operating income of $43 million in the corresponding period. Results were affected by a $41 million non-cash impairment of Shank's goodwill, in addition to write-downs of non-wrapper dark air-cured tobacco inventory.

In fiscal 2026, revenue was $2.9 billion and gross profit was $472.6 million, with a gross margin of approximately 16.3%, while net income declined to $32.6 million and earnings per share to $1.3. Annual operating income was $169 million, down $64 million from fiscal 2025, while net income reported on the call fell to $33 million from $95 million. The tobacco segment generated annual revenue of $2.6 billion and operating income of $212 million, while the food ingredients segment recorded revenue of $348 million and limited operating income of $3 million.

What's Driving the Stock

  • The most important operating driver is Universal's ability to manage the excess supply of flue-cured and burley tobacco during fiscal 2027; inventory not committed to sales obligations stood at 27% on March 31, 2026, and management expects it to return to a range of 10% to 20% during fiscal 2027.
Earnings callEDGAR filings30-day newsInsider activity

Automated analysis for informational purposes only — not investment advice.

  • The tobacco business continued to support revenue during Q4 fiscal 2026, as its revenue rose 3% to $632 million, despite operating income declining to $27 million from $46 million. Management sees opportunities to increase market share, volumes, and third-party processing services, while benefiting from the purchasing flexibility provided by large crops.
  • Improvement in the food ingredients segment depends on converting Shank's investments in production capacity, research and development, and commercial resources into sustainable sales volumes and margins. Segment operating income was only $3 million in fiscal 2026 compared with $12 million in fiscal 2025, so the initiatives focus on increasing facility utilization and improving commercial execution and operating efficiency.
  • Inventory normalization is a critical factor for earnings and cash flows, after tobacco segment inventory write-downs rose to $43 million in fiscal 2026, compared with $19 million in fiscal 2025 and an average of $14 million during fiscal years 2021 to 2025. Management confirmed on May 29, 2026 that it had conducted a comprehensive inventory review and was comfortable with its positions in light of the market conditions prevailing at that time.
  • Capital allocation supports the stock's appeal to income-seeking investors, as Universal announced its 56th consecutive annual dividend increase. Management says that the payout ratio, despite exceeding 100% of reported net income in fiscal 2026, remained below 75% based on adjusted net income over the previous five years.
  • Buying & Selling Case

    ▲ Buying Case4 pts

    • +The core tobacco business provides a broad business base, having generated $2.6 billion in revenue and $212 million in operating income in fiscal 2026, while the flue-cured and burley businesses remained strong according to management despite disruption in certain dark air-cured varieties.
    • +A decline in uncommitted inventory from 27% on March 31, 2026 to management's target range of 10% to 20% during fiscal 2027 could reduce working capital pressure and the risk of additional write-downs, if achieved within the specified period.
    • +The food ingredients platform has underutilized production capacity, technical capabilities, and existing investments in research and development, providing operating leverage if Shank's succeeds in converting customer interest and its product pipeline into sustainable sales. FruitSmart and Silva also performed in line with management's expectations during fiscal 2026 despite industry pressures.
    • +Available liquidity exceeded $1.2 billion on March 31, 2026, including cash and committed and uncommitted credit facilities. This liquidity gives the company the ability to finance working capital and invest in tobacco and food ingredients, while maintaining a dividend policy that has recorded 56 consecutive annual increases.

    ▼ Selling Case6 pts

    • −Universal depends heavily on tobacco, which generated $2.6 billion of its $2.9 billion in revenue in fiscal 2026, making its results highly sensitive to global oversupply and customer purchasing cycles. Management pointed to large flue-cured and burley crops and to inventory accumulation among customers after years of elevated purchases.
    • −Tobacco inventory write-downs rose to $43 million in fiscal 2026, compared with $19 million in fiscal 2025 and a five-year average of $14 million. Despite the inventory review in Q4 fiscal 2026, realizable value remains exposed to changes in prices, demand, and quality because inventory is recorded at the lower of cost or net realizable value.
    • −The food ingredients segment faces clear weakness in profitability; its annual operating income declined to $3 million from $12 million, and Shank's recorded a $41 million non-cash goodwill impairment. Management acknowledged that execution of the commercial strategy was behind schedule on March 31, 2026, and that converting customer interest into sustainable revenue and margin growth may take time.
    • −Earnings deteriorated in fiscal 2026 despite relatively stable revenue, as operating income declined by $64 million to $169 million, and net income fell to approximately $33 million from $95 million in fiscal 2025. In Q4 fiscal 2026 alone, the company recorded a net loss of $43.3 million and a gross margin of approximately 10.6% according to EDGAR data.
    • −Net debt rose to $845 million on March 31, 2026 from $817 million a year earlier, due to increased use of working capital to purchase and sell a significantly larger tobacco crop. Despite available liquidity exceeding $1.2 billion, continued excess inventory or slow sales could delay debt reduction and increase cash flow sensitivity to the agricultural cycle.
    • −Dividends exceeded 100% of reported net income in fiscal 2026, meaning that accounting earnings for that year did not fully cover the distributions. Management's confidence is based on an adjusted payout ratio below 75% over the previous five years, but continued weakness at Shank's or recurring inventory write-downs could pressure dividend coverage in the future.

    Valuation

    The stock carries a consensus Buy rating, but the available data does not include a consensus price target or a range between the highest and lowest targets that can be used as a fixed reference. The 52-week range extends from $43.36 to $59.38, while no reported P/E ratio is available; weak fiscal 2026 net income, the $41 million Shank's goodwill impairment, and the $43 million in inventory write-downs represent important financial reasons for the wide valuation range despite analysts' positive rating.

    Figures in the text are as of 2026-09-02; the live price is shown at the top of the page.

    FAQ

    What is the core business of Universal Corporation and its ticker UVV?

    Universal processes and sells leaf tobacco through a global network of sourcing regions and customers, and describes its business as a market leader with more than 100 years of experience. The tobacco segment generated revenue of $2.6 billion and operating income of $212 million in fiscal 2026. It also operates the Universal Ingredients platform, which comprises Shank's, FruitSmart, and Silva and focuses on plant-based, organic, and clean-label products.

    Why did UVV record a loss in Q4 fiscal 2026?

    The company recorded a net loss of $43.3 million in Q4 fiscal 2026, compared with net income of $9 million in the corresponding period according to the earnings call. Pressures included a $41 million non-cash impairment of Shank's goodwill and write-downs of non-wrapper dark air-cured tobacco inventory. Tobacco segment operating income also declined during that quarter to $27 million from $46 million, while food ingredients segment income fell to $2 million from $4 million.

    Why is the inventory issue important to Universal investors?

    Inventory not committed to sales obligations stood at 27% on March 31, 2026, as the market shifted from undersupply to balance and then oversupply during fiscal 2026. Tobacco inventory write-downs rose to $43 million in fiscal 2026, compared with $19 million in fiscal 2025 and a five-year average of $14 million. Management targets reducing the uncommitted inventory ratio to a range of 10%–20% during fiscal 2027, but achieving this depends on demand, crop movements, and customer requirements.

    Can the Universal Ingredients segment become a genuine growth driver?

    The food ingredients segment generated revenue of $348 million in fiscal 2026, up 3%, but its operating income declined to $3 million from $12 million. The main issue came from Shank's, where market conditions pressured core products and new product development, and the company recorded a $41 million goodwill impairment. The plan during fiscal 2027 focuses on increasing facility utilization and improving commercial execution and operating efficiency, while FruitSmart and Silva performed in line with management's expectations in fiscal 2026.

    How safe is UVV's dividend?

    In fiscal 2026, Universal announced its 56th consecutive annual dividend increase, reflecting a clear priority within its capital allocation policy. The payout ratio exceeded 100% of reported net income in fiscal 2026, although management said it remained below 75% based on adjusted net income over the previous five years. Available liquidity exceeded $1.2 billion on March 31, 2026, but net debt rose to $845 million, so the sustainability of coverage depends on an earnings recovery and improved working capital.

    What are the key items to monitor in fiscal 2027?

    Investors should monitor whether uncommitted inventory reaches management's target range of 10%–20% after standing at 27% on March 31, 2026. They should also follow whether the leadership reorganization within Shank's increases capacity utilization and converts the product pipeline into revenue and margin growth. The performance of flue-cured and burley will also be important, because management indicated on May 29, 2026 that large crops and excess supply persisted across global production regions.